Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Biogen Inc. (NASDAQ:BIIB)

Debt to Equity
since 2005

Beginner level

Calculation

Biogen Inc., debt to equity, long-term trends, calculation

Microsoft Excel LibreOffice Calc
Debt to equity = Notes payable1 ÷ Total Biogen Inc. shareholders’ equity1
Dec 31, 2019 0.45 = 5,954,800  ÷ 13,343,200 
Dec 31, 2018 0.46 = 5,936,500  ÷ 13,039,600 
Dec 31, 2017 0.47 = 5,938,200  ÷ 12,612,800 
Dec 31, 2016 0.54 = 6,517,400  ÷ 12,140,100 
Dec 31, 2015 0.70 = 6,526,300  ÷ 9,372,800 
Dec 31, 2014 0.05 = 585,197  ÷ 10,809,010 
Dec 31, 2013 0.07 = 595,927  ÷ 8,620,242 
Dec 31, 2012 0.16 = 1,140,775  ÷ 6,961,523 
Dec 31, 2011 0.17 = 1,064,100  ÷ 6,425,499 
Dec 31, 2010 0.22 = 1,203,532  ÷ 5,396,506 
Dec 31, 2009 0.18 = 1,099,969  ÷ 6,221,530 
Dec 31, 2008 0.19 = 1,113,098  ÷ 5,806,083 
Dec 31, 2007 0.28 = 1,562,978  ÷ 5,534,295 
Dec 31, 2006 0.01 = 96,694  ÷ 7,149,778 
Dec 31, 2005 0.01 = 43,444  ÷ 6,905,876 

Based on: 10-K (filing date: 2020-02-06), 10-K (filing date: 2019-02-06), 10-K (filing date: 2018-02-01), 10-K (filing date: 2017-02-02), 10-K (filing date: 2016-02-03), 10-K (filing date: 2015-02-04), 10-K (filing date: 2014-02-06), 10-K (filing date: 2013-02-05), 10-K (filing date: 2012-02-03), 10-K (filing date: 2011-02-04), 10-K (filing date: 2010-02-09), 10-K (filing date: 2009-02-06), 10-K (filing date: 2008-02-14), 10-K (filing date: 2007-02-21), 10-K (filing date: 2006-03-03).

1 US$ in thousands

Comparison to Competitors

Biogen Inc., debt to equity, long-term trends, comparison to competitors

Microsoft Excel LibreOffice Calc
Biogen Inc. Abbott Laboratories AbbVie Inc. Amgen Inc. Bristol-Myers Squibb Co. Eli Lilly & Co. Gilead Sciences Inc. Illumina Inc. Johnson & Johnson Merck & Co. Inc. Pfizer Inc. Regeneron Pharmaceuticals Inc. Vertex Pharmaceuticals Inc. Zoetis Inc.
Dec 31, 2019 0.45 0.58 — 3.09 0.91 5.88 1.09 0.25 0.47 1.02 0.83 0.06 0.09 2.38
Dec 31, 2018 0.46 0.64 — 2.71 0.52 1.30 1.28 0.53 0.51 0.94 0.66 0.08 0.13 2.95
Dec 31, 2017 0.47 0.90 7.33 1.40 0.68 1.18 1.64 0.49 0.57 0.71 0.60 0.11 0.29 2.80
Dec 31, 2016 0.54 1.07 7.95 1.16 0.41 0.74 1.39 0.58 0.39 0.62 0.71 0.11 0.71 3.00
Dec 31, 2015 0.70 0.42 8.03 1.12 0.47 0.55 1.20 0.60 0.28 0.59 0.60 0.10 0.86 4.56
Dec 31, 2014 0.05 0.36 8.62 1.19 0.53 0.52 0.80 0.88 0.27 0.44 0.51 0.18 0.75 2.78
Dec 31, 2013 0.07 0.26 3.28 1.45 0.55 0.30 0.58 0.57 0.25 0.50 0.48 0.26 0.36 3.89
Dec 31, 2012 0.16 0.77 4.66 1.39 0.54 0.37 0.88 0.64 0.25 0.39 0.46 0.37 0.68 0.14
Dec 31, 2011 0.17 0.63 — 1.13 0.34 0.52 1.13 0.75 0.34 0.32 0.47 0.90 0.58 —
Dec 31, 2010 0.22 0.85 — 0.56 0.35 0.56 0.59 0.26 0.30 0.33 0.50 0.31 1.07 —
Dec 31, 2009 0.18 0.72 — 0.47 0.43 0.70 0.18 0.34 0.29 0.30 0.54 0.27 0.14 —
Dec 31, 2008 0.19 0.65 — 0.50 0.55 1.55 0.31 0.47 0.28 0.33 0.30 0.00 1.20 —
Dec 31, 2007 0.28 0.69 — 0.63 0.59 0.37 0.38 0.97 0.22 0.32 0.20 0.43 0.07 —
Dec 31, 2006 0.01 0.88 — 0.48 0.74 0.34 0.77 0.00 0.17 0.39 0.11 0.92 0.24 —
Dec 31, 2005 0.01 0.46 — 0.19 0.77 0.60 0.10 0.00 0.07 0.45 0.27 1.75 0.75 —

Based on: 10-K (filing date: 2020-02-06), 10-K (filing date: 2019-02-06), 10-K (filing date: 2018-02-01), 10-K (filing date: 2017-02-02), 10-K (filing date: 2016-02-03), 10-K (filing date: 2015-02-04), 10-K (filing date: 2014-02-06), 10-K (filing date: 2013-02-05), 10-K (filing date: 2012-02-03), 10-K (filing date: 2011-02-04), 10-K (filing date: 2010-02-09), 10-K (filing date: 2009-02-06), 10-K (filing date: 2008-02-14), 10-K (filing date: 2007-02-21), 10-K (filing date: 2006-03-03).

Comparison to Sector (Pharmaceuticals & Biotechnology)

Biogen Inc., debt to equity, long-term trends, comparison to sector (pharmaceuticals & biotechnology)

Microsoft Excel LibreOffice Calc
Biogen Inc. Pharmaceuticals & Biotechnology
Dec 31, 2019 0.45 1.09
Dec 31, 2018 0.46 0.97
Dec 31, 2017 0.47 0.91
Dec 31, 2016 0.54 0.83
Dec 31, 2015 0.70 0.70
Dec 31, 2014 0.05 0.55
Dec 31, 2013 0.07 0.51
Dec 31, 2012 0.16 0.54
Dec 31, 2011 0.17 0.48
Dec 31, 2010 0.22 0.45
Dec 31, 2009 0.18 0.43
Dec 31, 2008 0.19 0.41
Dec 31, 2007 0.28 0.34
Dec 31, 2006 0.01 0.29
Dec 31, 2005 0.01 0.29

Based on: 10-K (filing date: 2020-02-06), 10-K (filing date: 2019-02-06), 10-K (filing date: 2018-02-01), 10-K (filing date: 2017-02-02), 10-K (filing date: 2016-02-03), 10-K (filing date: 2015-02-04), 10-K (filing date: 2014-02-06), 10-K (filing date: 2013-02-05), 10-K (filing date: 2012-02-03), 10-K (filing date: 2011-02-04), 10-K (filing date: 2010-02-09), 10-K (filing date: 2009-02-06), 10-K (filing date: 2008-02-14), 10-K (filing date: 2007-02-21), 10-K (filing date: 2006-03-03).

Comparison to Industry (Health Care)

Biogen Inc., debt to equity, long-term trends, comparison to industry (health care)

Microsoft Excel LibreOffice Calc
Biogen Inc. Health Care
Dec 31, 2019 0.45 0.90
Dec 31, 2018 0.46 0.82
Dec 31, 2017 0.47 0.83
Dec 31, 2016 0.54 0.79
Dec 31, 2015 0.70 0.71
Dec 31, 2014 0.05 0.53
Dec 31, 2013 0.07 0.50
Dec 31, 2012 0.16 0.52
Dec 31, 2011 0.17 0.46
Dec 31, 2010 0.22 0.43
Dec 31, 2009 0.18 0.41
Dec 31, 2008 0.19 0.41
Dec 31, 2007 0.28 0.36
Dec 31, 2006 0.01 0.33
Dec 31, 2005 0.01 0.30

Based on: 10-K (filing date: 2020-02-06), 10-K (filing date: 2019-02-06), 10-K (filing date: 2018-02-01), 10-K (filing date: 2017-02-02), 10-K (filing date: 2016-02-03), 10-K (filing date: 2015-02-04), 10-K (filing date: 2014-02-06), 10-K (filing date: 2013-02-05), 10-K (filing date: 2012-02-03), 10-K (filing date: 2011-02-04), 10-K (filing date: 2010-02-09), 10-K (filing date: 2009-02-06), 10-K (filing date: 2008-02-14), 10-K (filing date: 2007-02-21), 10-K (filing date: 2006-03-03).